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Acetohydroxyacid synthase (AHAS) and acetolactate
synthase (ALS) are thiamine diphosphate (ThDP)-
dependent enzymes that catalyze the decarboxylation of
pyruvate to give a cofactor-bound hydroxyethyl group,
which is transferred to a second molecule of pyruvate to
give 2-acetolactate. AHAS is found in plants, fungi, and
bacteria, is involved in the biosynthesis of the branched-
chain amino acids, and contains non-catalytic FAD. ALS
is found only in some bacteria, is a catabolic enzyme
required for the butanediol fermentation, and does not
contain FAD. Here we report the 2.3-Å crystal structure
of Klebsiella pneumoniae ALS. The overall structure is
similar to AHAS except for a groove that accommodates
FAD in AHAS, which is filled with amino acid side
chains in ALS. The ThDP cofactor has an unusual con-
formation that is unprecedented among the 26 known
three-dimensional structures of nine ThDP-dependent
enzymes, including AHAS. This conformation suggests a
novel mechanism for ALS. A second structure, at 2.0 Å, is
described in which the enzyme is trapped halfway
through the catalytic cycle so that it contains the hy-
droxyethyl intermediate bound to ThDP. The cofactor
has a tricyclic structure that has not been observed
previously in any ThDP-dependent enzyme, although
similar structures are well known for free thiamine.
This structure is consistent with our proposed mecha-
nism and probably results from an intramolecular pro-
ton transfer within a tricyclic carbanion that is the true
reaction intermediate. Modeling of the second molecule
of pyruvate into the active site of the enzyme with the
bound intermediate is consistent with the stereochem-
istry and specificity of ALS.
The enzyme EC 2.2.1.6 (formerly EC 4.1.3.18) known both as
acetolactate synthase (ALS)1 and as acetohydroxyacid syn-
thase (AHAS) catalyzes the conversion of 2 mol of pyruvate to
acetolactate plus CO2 (1). These two different names for the
enzyme distinguish two forms (2) that have distinctly different
properties. One difference is that AHAS requires FAD, whereas
ALS is FAD-independent. However, ALS and AHAS are clearly
related proteins with substantial sequence similarities and
share a requirement for thiamine diphosphate (ThDP).
In most flavin-containing enzymes that catalyze non-redox
reactions (3), the cofactor has been shown, or is suspected, to
play an internal role as an electron acceptor/donor. For exam-
ple, in chorismate synthase, flavin mononucleotide participates
in free radical chemistry (4). The exception is hydroxynitrile
lyase, where there appears to be no internal redox role (5). In a
curious parallel to ALS/AHAS, this enzyme exists in two forms,
only one of which contains FAD (6).
The three-dimensional structure of the FAD-dependent al-
mond hydroxynitrile lyase (7) suggests that the cofactor is an
evolutionary remnant of an aryl alcohol oxidase progenitor.
Similarly, AHAS may have evolved from a pyruvate oxidase
ancestor (8). Our determination of the structure of the FAD-
dependent yeast AHAS (9) supports this idea; FAD is located
close to the active site and in a position similar to that in
pyruvate oxidase. The function of FAD in AHAS appears to be
solely for maintenance of structural integrity.
An alternative approach to unraveling the role of FAD in
AHAS is to understand how the FAD-independent ALS can
dispense with this cofactor. This enzyme, from Aerobacter aero-
genes, was crystallized in 1967 (10), but no x-ray diffraction
studies were reported. We obtained diffraction-quality crystals
of the enzyme from the closely related bacterium Klebsiella
pneumoniae (11); now we report the three-dimensional struc-
ture of this ALS.
ThDP-dependent enzymes are ubiquitous in nature and are
involved in all major metabolic processes. It is generally accepted
that the initial step in catalysis by these enzymes is the depro-
tonation of the thiazolium ring at the C-2 atom (Fig. 1, A, I3 II,
and B). Elucidation of the structure of several ThDP-dependent
enzymes (12–18) has allowed a plausible mechanism for this
ionization to be proposed, involving a conserved glutamate, N-1,
and the 4-amino group. Studies with cofactor analogs (19) and by
mutagenesis (20–24) support this mechanism.
The high specific activity of K. pneumoniae ALS (10) corre-
sponds to a kcat of 533 s
1 which is about 10-fold higher than
that of any FAD-dependent AHAS (e.g. Ref. 25) showing that
FAD independence does not cripple the enzyme. Quite the
reverse; the FAD-dependent enzyme is unable to achieve rate
enhancements that are attainable by ALS. The kcat value of
K. pneumoniae ALS is significantly higher than that of any
ThDP-dependent enzyme with a known structure. The kcat
value is also substantially higher than the observed rate con-
stant for C-2 deprotonation in Zymomonas mobilis pyruvate
decarboxylase and in yeast transketolase (26), suggesting that
the environment of ThDP in K. pneumoniae ALS might be
especially favorable for C-2 deprotonation.
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Here we report, at 2.3-Å resolution, the structure of the
enzyme containing ThDP and the other essential cofactor
Mg2; henceforth, this complex will be denoted the “resting”
enzyme. ThDP is bound in a conformation that is slightly, but
significantly, different from that found in all other ThDP-de-
pendent enzymes. We propose a mechanism for C-2 deprotona-
tion that implies an active role for the sulfur atom of ThDP,
similar to a suggestion by Kluger (27).
Only two of the reported structures of ThDP-dependent en-
zymes have intermediates attached to the cofactor. These are
pyruvate:ferredoxin oxidoreductase (28) containing the acetyl
radical of ThDP (formed from pyruvate) and transketolase (29)
with the -carbanion or enamine of dihydroxyethyl-ThDP
(formed from hydroxypyruvate). For both enzymes, trapping of
the intermediate results because no acceptor substrate is pres-
ent to complete the catalytic cycle. For 2-ketoacid decarboxyl-
ases such as pyruvate decarboxylase, there is no second sub-
strate, so intermediate capture does not seem to be feasible.
Superficially, the same is true for ALS/AHAS; although there is
a second substrate, it cannot be omitted because it is chemi-
cally identical to the first substrate. However, we realized that
the catalytic cycle of ALS/AHAS possesses an unusual feature
that makes intermediate capture inevitable, as we shall show
later. The second structure reported here, at both 2.0- and
2.3-Å resolution, is of K. pneumoniae ALS containing the inter-
mediate formed after decarboxylation of the first pyruvate. The
intermediate formed appears to be the hydroxyethyl derivative
of the tricyclic form of ThDP.
MATERIALS AND METHODS
Expression and purification of K. pneumoniae ALS were as described
previously (11). Prior to crystallization, the enzyme was concentrated to
9 mg/ml in 50 mM potassium phosphate buffer (pH 7.0) containing 1 mM
ThDP, 1 mM MgCl2, and 1 mM DTT. Crystals of the enzyme grown in
hanging drops (1 l of reservoir solution and 1 l of protein solution)
and incubated at 17 °C appeared overnight and reached their maximum
size in 2 weeks. The reservoir solution consisted of 0.1 M Na-Hepes (pH
7.5–7.7), 6–8% (w/v) PEG8000, and 6–9% (v/v) ethylene glycol. The
crystals reported previously (11) belong to the space group C2, and
diffract to 2.6-Å resolution, but in subsequent crystallization experi-
ments using the same conditions, orthorhombic and triclinic crystals
were obtained (Table I). Because the C2 crystals diffract to moderate
resolution only, further structural studies were pursued with the new
crystal forms. To trap the intermediate, orthorhombic and triclinic
crystals were soaked in 200 mM pyruvate (Km  34.1  3.9 mM) for 1
week. For cryoprotection, crystals were transferred to 5 l of reservoir
solution containing 30% (v/v) PEG600.
For this study, three complete data sets were collected; one of the
resting enzyme (i.e. without added pyruvate) and two of the enzyme-
intermediate complex formed by soaking with pyruvate. An orthorhom-
bic crystal was used to collect data on the resting enzyme, and data from
an orthorhombic and a triclinic crystal were collected for the enzyme-
intermediate complex. The three data sets were collected on Beam-Line
14D at the Advanced Photon Source in the Argonne National Labora-
tory, Chicago. The data were indexed, integrated, and scaled using the
programs DENZO and SCALEPACK (30).
The structures of the enzyme-intermediate complex, in the ortho-
rhombic and triclinic crystals, were solved concurrently using AMoRe
(31). The search molecule for both forms was a dimer of the core region
(residues 94–256, 289–383, 403–438, and 491–646) of the catalytic
subunit of yeast AHAS (PDB code 1JSC, see Ref. 9). By using the AHAS
dimer as the probe, two peaks in the rotation function were observed,
both of which had correlation coefficients of 0.257. This compared with
a correlation coefficient of 0.067 for the next highest peak. The trans-
lation function positioning the second dimer relative to the first was
next calculated. The highest peak resulted in assembly of the expected
tetramer. The correlation coefficient for this solution was 0.448. Rigid
body refinement of the model, using data from 15 to 4 Å, gave an Rfactor
of 0.424. For the orthorhombic crystal, a dimer in the asymmetric unit
was observed in the rotation and translation function calculations. The
solution had a correlation coefficient of 0.290 and an Rfactor of 0.550.
Rigid body refinement of the model, using data from 15 to 4 Å, gave a
correlation coefficient of 0.560 and an Rfactor of 0.437. The structure of
the resting enzyme was determined using the coordinates of the ortho-
rhombic enzyme-intermediate complex as a starting point. Model build-
ing and refinement of the three structures were carried out using the
program O (32) and the CNS software package (33). The final values for
Rfree and Rfactor and the errors in the model geometry for the three
structures are listed in Table I. The coordinates and structure factors
have been deposited with the RCSB Protein Data Bank with PDB codes
1OZF (orthorhombic resting enzyme), 1OZG (orthorhombic  pyru-
vate), and 1OZH (triclinic  pyruvate). Figures were generated with
SETOR (34), MOLSCRIPT (35), Raster3D (36), ChemSketch (Advanced
Chemistry Development Inc., Toronto, Canada), ESPript (37) and IN-
SIGHT2000.1 (Accelrys).
RESULTS
Resting Enzyme
Overall Structure of the Resting Enzyme—K. pneumoniae
ALS is composed of 559-residue subunits (38), thought to be
arranged as a homotetramer as in its A. aerogenes counterpart
(39). The recombinant ALS that we have crystallized possesses
a native N-terminal sequence but has seven additional C-ter-
minal residues, glutamate followed by a hexahistidine se-
quence. The asymmetric unit in the resting enzyme consists of
a dimer, with the other half of the tetramer related by a
crystallographic 2-fold axis of symmetry (Fig. 2A). Electron
density for one subunit (arbitrarily designated monomer A)
extends from Val7–His554, except that there is a three-residue
gap from Ser184–Ala186 in a linker between two domains. No
side-chain electron density beyond the -carbon atom was vis-
ible for three polar surface residues Gln188, Lys208, and Lys225.
Electron density for monomer B extends by two additional
residues at the N terminus but has three gaps: at Val118–Gln120
(surface loop), at Ser184–Ala186 (domain linker), and at Arg362–
FIG. 1. The catalytic cycle of ALS and AHAS. The accepted view (A) is that enzyme-bound ThDP (I) ionizes to give the carbanion (II) that
then reacts with pyruvate to give lactyl-ThDP (III). After decarboxylation, the intermediate formed (IV) reacts with a second molecule of pyruvate
to give acetolactyl-ThDP (V). Release of acetolactate completes the catalytic cycle. B shows the structure of ThDP.
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Gly363 (domain boundary). In monomer B, no side-chain elec-
tron density beyond the -carbon atom was visible for seven
polar surface residues Gln117, Gln188, Arg228, Glu289, Arg312,
Arg350, and Arg361.
Each monomer is composed of three distinct domains (Fig.
2B), designated from the N terminus as the -, -, and -do-
mains. The -domain extends from the observable N terminus
to Ala183; the -domain spans residues Pro193–Ser342, and the
-domain commences at Asp360 and extends to the observable C
terminus. The connector between the - and -domains is a
9-residue random coil, partly undefined in both monomers. The
connector between the - and -domains is a well defined
17-residue -helix, Pro343–Leu359 (Fig. 3, 13). The - and
-domains are each built around a six-stranded parallel -sheet
with the same Richardson topology of 1x, 2x, 1x, 2x,
1x, surrounded by -helices. The -domain has an additional
short anti-parallel -sheet (Fig. 3, 1/8) derived from the N-
and C-terminal sections of the domain. The -domain has a
six-stranded parallel -sheet with a Richardson topology of
1x, 1x, 3x, 1x, 1x. This -sheet forms part of a double
Rossmann fold. The two monomers are very similar and when
overlaid yield a root mean square deviation (r.m.s.d.) of 0.68 Å
for 536 equivalent C atoms. The most prominent difference is
in a small loop that precedes the Val118–Gln120 gap in monomer
B. The remaining differences are in the -domain, which is
shifted slightly relative to the remainder of the protein.
All ThDP-dependent enzymes have this cofactor bound at the
active site in a domain interface, and in most cases the domains
are derived from different subunits. The same is true of ALS;
however, the crystallographic subunit pair does not correspond
to the pair that forms the active site (Fig. 2A). Two identical
active sites are formed at the interface between monomer A
and its symmetry partner. Similarly, monomer B and its sym-
metry partner form a second pair of identical active sites. Thus,
the two functional dimers are each symmetrical but slightly
different from one another. These differences most likely orig-
inate from crystal packing forces.
Comparison with the FAD-dependent AHAS—The primary
and secondary structures of ALS are very similar to those of the
FAD-dependent AHAS (Fig. 3). The three-dimensional struc-
tures are also very similar. When the -domains are overlaid
(r.m.s.d.  1.23 Å for 168 C atoms), the only noticeable dif-
ference is in a loop comprising residues Ala112–Asp123, which
adopts a different conformation in the two proteins. This region
FIG. 2. Structure of K. pneumoniae ALS. A shows a ribbon diagram of the overall structure of the resting enzyme tetramer, with the
monomers colored green (monomer A), red (B), blue (C), and yellow (D). There is a vertical 2-fold axis of symmetry in this view. The asymmetric
unit contains monomers A and B, whereas the active sites are at the AC and BD interfaces. Monomer A is shown in B, with cylinder representations
of -helices (red) and -strands (turquoise) shown as arrows, connected by random coil (green). C and D compare the -domains of ALS (C) and
AHAS (D), with secondary structure indicated as in B. The residues in contact with FAD (stick model, D) in AHAS and their structural equivalents
in ALS (C) are shown in surface representation.
Crystal Structure of Acetolactate Synthase2244
 at UQ Library on October 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
FIG. 3. Structure-based sequence alignment of K. pneumoniae ALS (resting enzyme, monomer A) and yeast AHAS (monomer A, 40),
drawn with the program ESPript (37). The schematics above and below the sequences represent -helices (1, 2, etc.), -strands (1, 2, etc.)
and 310 helices (1, 2, etc.), and TT represents -turns. Residues shown in boxes are similar between the two sequences, those printed white on
black are identical, and those shown in lowercase are not visible in the electron density map of the proteins.
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in ALS is located at the dimer-dimer interface of the tetramer.
Yeast AHAS, on the other hand, does not form a homotetramer
and exists as a dimer in both solution and crystals. The -do-
mains are also very similar between ALS and AHAS (r.m.s.d.
1.44 Å for 166 C atoms). However, AHAS has a C-terminal
extension as described previously (40) that is not found in ALS
(Fig. 3).
The -domains of the two proteins are the most different of
the three domains, with a higher r.m.s.d. value (1.49 Å) for
fewer (133) C atoms. In general, this domain in both enzymes
has a similar secondary structure topology, consisting of a
central six-stranded parallel -sheet surrounded by helices and
loops. The major differences are in the connections between the
strands of the central -sheet. An example is the polypeptide
segment connecting the -strands 12 and 13 (Fig. 3). In yeast
AHAS this segment, comprising residues Gly374 to Gly401, con-
sists of two helices that are separated by a random coil. The
corresponding region in ALS (Gly282–Ala298) is 11 residues
shorter and has two short helices, but neither corresponds to
those found in AHAS.
The most obvious difference between the structures of ALS
and AHAS is that the latter contains FAD. In AHAS, the
FAD-binding site is located mainly in the -domain. FAD binds
near the C-terminal edge of the central parallel -sheet and
forms multiple interactions with a series of loop regions found
on the surface of the domain. Most of the interacting amino acid
residues are highly conserved among AHAS sequences across
plant and fungal and bacterial species. The surface topology of
the binding site shows clearly that FAD, in an extended con-
formation, lies in a groove that runs across the -domain (Fig.
2D). This groove structure is missing from the surface topology
of the corresponding area in the -domain of ALS (Fig. 2C). The
absence of the groove structure in ALS is brought about by
slightly different orientations of the surface loop regions, and
by amino acid substitutions to bulky hydrophobic residues at
positions that interact with FAD in AHAS.
Structure of ThDP in the Resting Enzyme—ThDP is bound at
a subunit interface, anchored at one end through a magnesium
ion that is octahedrally coordinated to six oxygen atoms: one
from each phosphate group, one from the side chains of Asp447
FIG. 4. Structures and stereo electron density maps for ThDP in K. pneumoniae ALS. A shows the Fo  Fc difference electron density
map (contoured at 5) for the resting enzyme before ThDP is modeled. The coordinates with a planar N-3 (brown) and pyramidal N-3 (blue) are
overlaid for comparison. B and C show two views of the Fo  Fc difference electron density map before hydroxyethyl-ThDP was modeled (contoured
at 5) for the enzyme intermediate. The coordinates of the modeled tricyclic structure are shown in blue and the non-tricyclic model in brown.
D, the coordinates of ThDP with a pyramidal N-3 (dark blue) and the tricyclic intermediate (light blue) are overlaid. E and F show the Fo  Fc
electron density after modeling of the tricyclic (E) and non-tricyclic (F) enzyme-intermediate with a C-2 to N-4 distance of 2.5 Å. Green density
is contoured at 3 and red density at  3.
Crystal Structure of Acetolactate Synthase2246
 at UQ Library on October 16, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
and of Asp474, the backbone of Gly476, and one water molecule.
The arrangement of ligands is slightly unusual compared with
other ThDP-dependent enzymes in that the amino acid side-
chain ligands are usually an aspartate and an asparagine,
which are found at the two ends of the “thiamine-binding
motif” discovered by Hawkins et al. (41). The asparagine is
FIG. 5. Proposed structures in the catalytic cycle of K. pneumoniae ALS. See text for details. I–V correspond to those in Fig. 1A.
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highly conserved (42) with the possible exception of ALS se-
quences. In Z. mobilis pyruvate decarboxylase, mutation of the
equivalent asparagine to aspartate results in a drastic reduc-
tion in the affinity for ThDP (43). The reason that ALS uses
aspartate rather than asparagine as a magnesium ion ligand is
therefore not clear. What is clear is that the presence of both
ThDP and magnesium ion lays to rest the suggestion (38) that
K. pneumoniae ALS does not require these cofactors.
The first step in catalysis by ThDP-dependent enzymes is
widely believed to be the ionization of the thiazolium ring of
ThDP (Fig. 1A, I3 II). In both ThDP (Fig. 1B) and the result-
ing C-2 carbanions, the thiazolium ring is expected to be planar
with its aromaticity producing C-2—N-3 and C-4—C-5 bonds
with lengths approaching those of double bonds. This expecta-
tion is confirmed in the structures of all ThDP-dependent en-
zymes containing unmodified ThDP. The bond from N-3 to
C-7, which connects to the methylaminopyrimidine ring, is
normally in the same plane as the thiazolium ring due to sp2
hybridization at N-3. This geometry is observed in the struc-
tures of all ThDP-dependent enzymes containing unmodified
ThDP. In K. pneumoniae ALS the thiazolium ring is planar, but
the angle between the electron density associated with the
thiazolium and methylaminopyrimidine rings is more acute
than that in any of the 26 known three-dimensional structures
of nine ThDP-dependent enzymes.
In order to fit the two rings into the observed electron density
while maintaining planarity at N-3 (Fig. 4A), it is necessary to
propose a bond angle of 96° at C-7 and of 90° at the methylene
that links to the diphosphate tail of the cofactor. These unfa-
vorable angles are each about 15° more acute than those ob-
served in other ThDP-dependent enzymes, which average 111°
(range 107–115°) and 107° (range 103–112°), respectively. An
alternative explanation is that the structure is pyramidal at
N-3 (Fig. 4A), resulting in acceptable bond angles of 110° and
104°, respectively. At 2.3-Å resolution the electron density is
not sufficiently well resolved to discriminate between the two
possibilities. However, our preferred model is that with a py-
ramidal N-3 because there is a reasonable mechanism that
could give rise to this structure.
A pyramidal N-3 could arise from an improbable reduction
by DTT to the thiazoline (44) or by charge migration from N-3
to S-1 (Fig. 5, Ia). Kluger (27) noted the importance of Ia to the
probable structure of the carbanion. Although this S form is
expected to be less favored than the N form, the difference in
stability between the two forms may be small. In the crystal
structure of ThDP itself (45), the N form is favored by a factor
of 2.16:1 only. Moreover, the Met394 backbone carbonyl dipole,
3.9 Å from S-1 but 6.3 Å from N-3, may provide some weak
stabilization of the S form. Irrespective of how it is stabilized,
we suggest that the structure observed is the Ia/Ib resonance
hybrid with Ib as a significant contributor. However, we cannot
rule out C-2 proton dissociation giving the resonating sulfur
ylide/carbene (IIa/IIb).
In all ThDP-dependent enzymes, the two rings of the cofactor
are held in a V conformation by a large hydrophobic residue
intruding between them. For example, in yeast AHAS it is
Met525 that performs this role. The structurally equivalent
residue in K. pneumoniae ALS is Met422, and the position of
this methionine is quite similar in the two enzymes (not
shown), with a C separation of only 0.64 Å. The position of
Met422 allows a pyramidal N-3, but it does not force this con-
formation. Observations on the structure of ALS containing a
bound intermediate, to be described below, suggest an expla-
nation for the unusual conformation. This hypothesis will be
developed under “Discussion,” but it involves formation of the
tricyclic form IIc (Fig. 5).
ALS with a Bound Intermediate
Rationale for the Addition of Pyruvate—Crystals of the en-
zyme were soaked with pyruvate to convert the enzyme to
intermediate IV (Fig. 1A). The overall reaction catalyzed by
ALS is irreversible, and it may not be immediately apparent
why addition of pyruvate would cause the accumulation of
what is, ostensibly, a transient intermediate. However, when
the catalytic cycle of the enzyme (Fig. 1A) is dissected, it can be
shown that accumulation of this intermediate is not only pos-
sible, it is obligatory. Addition of pyruvate initiates the cata-
lytic cycle, which proceeds in a predominantly clockwise direc-
tion as illustrated in Fig. 1A. In the steady state, IV represents
a small fraction of the total enzyme present, but as acetolactate
accumulates, reversal of the step I 3 V becomes possible.
Accumulation of acetolactate is accompanied by depletion of
pyruvate so V3 IV is increasingly favored. For as long as some
pyruvate remains, all enzyme forms will coexist in steady-state
equilibrium. However, the pyruvate concentration will be
driven to zero eventually by reaction with II forming III, which
is converted irreversibly to IV. At the same time, IV 3 V
becomes impossible because there is no pyruvate remaining.
The combination of these processes forces the total active en-
zyme to collect as IV.
To verify this logic, a simulation was performed (Fig. 6) by
using the program Wes (46). We do not suggest that the sim-
ulation illustrated reproduces quantitatively the time course of
the various intermediates, and we did not perform an exact
simulation because we do not know the values of the various
rate constants. However, no matter what rate constants are
assumed, the simulation always terminates with IV as the
final form. The only escape would be the release of acetalde-
hyde to produce I, a reaction that is not part of the catalytic
cycle and is expected to be suppressed by ALS. Even if this
reaction does occur slowly, the built-up acetolactate would en-
sure that IV is immediately reformed from I via V.
Overall Structure of the Protein—Crystals in two different
space groups (Table I) were treated with pyruvate to trap the
intermediate. The triclinic form has the highest resolution at
FIG. 6. Simulation of the time-dependent distribution of en-
zyme complexes as pyruvate is consumed by ALS. Complexes I
and II (Fig. 1A) were treated as a single species. The rate constants
assumed are as follows: I/II 3 III, 2.5  104 M1 s1; III 3 I/II, 1.0 
103 s1; III 3 IV, 1.5  103 s1; IV 3 V, 7.0  105 M1 s1; V 3 IV,
5.0  101 s1; V3 I/II, 5.5  102 s1; and I/II3 V, 1.0  105 M1 s1.
This combination of rate constants results in kcat and Km values of 500
s1 and 34.1 mM, respectively. Initial concentrations of pyruvate and
ALS were set at 200 mM and 50 M, respectively. Simulations were
performed with the program Wes (46). The dashed line shows pyruvate
consumption, and the solid and dotted lines show the concentrations of
I/II and IV, respectively. When pyruvate consumption exceeds 99%
after about 0.7 min, there is a sharp rise in the amount of IV, and at 3
min this enzyme form represents about 85% of the total. The percentage
of IV rises above 98% upon continuing the simulation (not shown) for a
further 12 min and eventually reaches 100%.
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2.0 Å, and the asymmetric unit is a tetramer. For the orthor-
hombic form, the asymmetric unit contains two monomers and
diffracts to 2.3 Å, the same as this form when not soaked with
pyruvate. There are only marginal differences between the
triclinic and orthorhombic forms, and here we shall focus on the
latter when describing the protein structure. When we look in
detail at the intermediate, the data from the triclinic form will
be used because it has the higher resolution.
Monomer A extends from Pro6 to His554 and contains no
internal gaps, whereas monomer B has one additional N-ter-
minal residue and has gaps at Val118–Gln120, Gly185, and
Gly363. No side-chain electron density beyond the -carbon is
observed for Lys114, Ser184, Lys208, and Lys225 in monomer A
and Gln117, Ser184, Gln188, Arg350, Arg361, and Arg362 in mon-
omer B. The overall structure of the two monomers is almost
identical with an r.m.s.d. of 0.70 Å for 540 C atoms. Compar-
ing each monomer with the two of the resting enzyme, the
differences are again rather small; of the four possible pairwise
comparisons, the highest r.m.s.d. is 0.78 Å for 536 C atoms.
When the active site regions of the resting and enzyme-inter-
mediate forms are compared, the positions of all amino acid
side chains are identical within the resolution of the data.
Structure of the Intermediate—The geometry of ThDP in the
intermediate is subtly different from that in the resting en-
zyme. One major difference is the presence of additional elec-
tron density that projects from C-2 (Fig. 4, B and C), consistent
with the presence of the S-enantiomer of an hydroxyethyl
group attached to the cofactor. A further difference is that the
methylaminopyrimidine and thiazolium rings are closer to one
another than in the resting enzyme. We investigated a variety
of conformational alternatives for the cofactor, but these invari-
ably left unexplained electron density between N-4 and C-2
(Fig. 4F). Even when these two atoms were separated by 2.2 Å
only, closer than the sum of their van der Waals radii (2.95 Å),
unexplained density remained. Our interpretation is that there
is a covalent bond connecting N-4 and C-2 (Fig. 4E).
The resulting tricyclic compound (IVc, Fig. 5) is identical to
dihydrothiachrome diphosphate except for the extra substitu-
ent on C-2. The formation of dihydrothiachrome by cyclization
of thiamine in alkaline ethanol was first detailed by Maier and
Metzler (47). Oxidation of this compound gives rise to thio-
chrome (48), the fluorescent derivative that is used widely for
estimating thiamine and its derivatives. Later studies have
reported the formation of dihydrothiachrome in basic (49) and
neutral (50) aqueous solution. It was suggested (51), before the
structure of any ThDP-dependent enzyme was known, that the
tricyclic form may be catalytically important as a means of
protecting ThDP from hydrolysis. Even though the enzyme
structures published subsequently have not favored this hy-
pothesis, Zoltewicz and Uray (49) do not rule it out. Similar
tricyclic structures may form in other ThDP-dependent en-
zymes, and in this context we note that the drug omeprazole,
TABLE I
Data collection and refinement statistics
Resting Intermediate Oa Intermediate Ta
Crystal data
Unit cell length (Å) a  116.8 a  117.5 a  86.3
b  160.6 b  160.6 b  92.8
c  129.4 c  129.5 c  97.4
Unit cell angle (°)   90.0   90.0   68.0
  90.0   90.0   63.5
  90.0   90.0   67.7
Space group C2221 C2221 P1
Crystal dimensions (mm) 0.2  0.05  0.05 0.2  0.05  0.05 0.3  0.3  0.05
Diffraction datab
Temperature (K) 100 100 100
Resolution range (Å) 100–2.3 100–2.3 100–2.0
Observations [I0(I)] 195,326 (4677) 170,273 (5047) 285040 (17,104)
Unique reflections [I0(I)] 48,069 (2370) 48,466 (3030) 153,254 (11,633)
Completeness 87.5 (43.7) 88.2 (49.3) 93.8 (71.3)
Rsym
c 0.055 (0.113) 0.057 (0.126) 0.030 (0.14)
	I
/	(I)
 21.5 (5.6) 17.7 (4.5) 29.2 (4.6)
Refinement
Resolution limits (Å) 100–2.3 100–2.3 100–2.0
Monomers per asymmetric unit 2 2 4
No. atoms per asymmetric unitd
Protein non-H 8204 (24.4) 8256 (25.6) 16,260 (33.1)
ThDP non-H 2  26 (21.1)
ThDP/intermediate non-H 2  29 (18.7) 4  29 (22.9)
Mg2 2 (13.9) 2 (12.8) 4 (24.2)
Phosphate non-H 2  5 (16.4) 2  5 (19.8) 4  5 (40.6)
Diethylene glycol non-H 9  7 (45.0) 8  7 (50.0) 5  7 (52.9)
Triethylene glycol non-H 2  10 (48.9)
Water molecules 527 (34.1) 612 (36.3) 1335 (42.3)
Rfactor 0.165 0.162 0.191
Rfree 0.215 0.214 0.228
Root mean square deviations
Bond lengths (Å) 0.005 0.005 0.005
Bond angles (°) 1.24 1.23 1.26
Ramachandran plot (%)
Most favored 91.1 90.6 90.6
Additionally allowed 8.8 9.4 9.3
Generously allowed 0.1 0.0 0.1
Disallowed 0.0 0.0 0.0
a Enzyme-intermediate complex, formed by soaking orthorhombic (O) or triclinic (T) crystals with 200 mM pyruvate.
b Values in parentheses are statistics for the highest resolution shell, 2.38 to 2.30 Å for the orthorhombic crystals and 2.07 to 2.00 Å for the
triclinic crystal.
c Rsym  I	I
/	I
, where I is the intensity of an individual measurement of each reflection and 	I
 is the mean intensity of that reflection.
d Values in parentheses are average B-factors, in Å2.
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an analog of the tricyclic form of thiamine, inhibits Z. mobilis
pyruvate decarboxylase by competing with ThDP (52).
The structure that we propose has not been identified previ-
ously as a possible intermediate of a ThDP-dependent enzyme.
Indeed, we think that it is more likely to be a non-productive
complex (IVc, Fig. 5) formed in a side reaction from the true
intermediate (IVb, Fig. 5). We suggest that the highly reactive
tricyclic intermediate (IIc, Fig. 5) first forms prior to addition
of the first pyruvate, and this reacts with the substrate forming
III that then decarboxylates to give the relatively non-reactive
enamine (IVa, Fig. 5). Because this is stable, the enzyme can
pause midway through the catalytic cycle while releasing CO2
and admitting the second molecule of pyruvate. The tricyclic
-carbanion (IVb, Fig. 5) then forms, ready to react with the
second pyruvate. However, occasionally during the prolonged
incubation that occurs after the soaked crystals have used up
all of the added pyruvate, a small fraction of the accumulated
IVa flickers into IVb and is converted to IVc, which is the
stable product that we observe. This two-step route (IVa 3
IVb3 IVc) appears to be the more likely, although we cannot
rule out direct conversion of IVa to IVc.
The conversion of IVb to IVc involves protonation of C of
the intermediate and deprotonation of N-4. Although these
could be unconnected events, we suggest that there is an in-
tramolecular proton transfer. The basis of this suggestion is
that the hydrogen atom on C of IVc is in a hydrophobic region
with no suitable amino acid side chains or water molecules that
might be a proton source. The N-4 hydrogen atom on the
hydrophobic face of IVb is well positioned to act as a source of
the C proton, with a C to N distance of 2.4 Å.
Active Site and a Second Substrate Binding Model
As in AHAS, the active site of ALS is located at a dimer
interface, situated at the bottom of a funnel about 15–20 Å from
the surface of the protein. The inner face of this funnel is
bordered by amino acids from all three domains and from both
monomers of the functional dimer. When the active sites of ALS
and AHAS are compared (Fig. 7, A and B), the similarities
between the type and orientation of functional groups are ap-
parent. In both enzymes, the C-2 reaction center is flanked on
one side by a hydrophobic residue and on the other side by a
glutamine. The hydrophobic residues (Met479 in ALS and
Met582 in AHAS) are conserved both in their positions within
the active sites as well as in the primary sequences. On the
other hand, the glutamine residues (Gln420 in ALS and Gln202
in AHAS) occupy similar positions in the active sites but are
from totally different parts of the proteins; Gln420 in ALS is
from the -domain, and Gln202 in AHAS is from -domain and
a different monomer. There is growing recognition (53) that
related proteins can have spatially equivalent functional
groups in their active sites that occupy different positions in
their amino acid sequences.
FIG. 7. The active sites of ALS and AHAS. A shows the active site region of K. pneumoniae ALS (resting enzyme), and B shows the active site
of yeast AHAS viewed in a similar orientation. Residues with and without the prime symbol are derived from different monomers. C, the active
site of ALS is shown with the second molecule of pyruvate modeled in so that it makes favorable contacts and is orientated so that it would yield
the S-enantiomer of acetolactate (D). In this model, the intermediate is represented as the tricyclic carbanion (IVb, Fig. 5), and an alternate
conformation of Lys36 is shown for which the -amino group forms an ionic interaction with the carboxylate of the second pyruvate.
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The second half of the ALS/AHAS catalytic cycle (Fig. 1A)
involves the combination of the reaction intermediate (IV) with
the second substrate to yield the bound product complex (V)
that then releases an acetohydroxy acid. The formation of the
product intermediate is stereospecific, and the incoming sub-
strate must be correctly orientated. This might involve an ionic
interaction between the carboxylate group and a basic residue
in the active site. The only available candidate residues are
Lys36 in ALS and Lys251 in AHAS. As with the Gln420/Gln202
pair, the lysine residues are not from corresponding positions
in amino acid sequence, but they are found in similar locations
within the active sites of the two enzymes. These lysines are
highly conserved within the two groups of enzymes, and their
side chains are not involved in ionic interactions with other
parts of the protein. We suggest that they are involved in
binding and orientating the second substrate.
By using the information from the crystal structures and the
reaction stereochemistry, a model for the binding of the second
substrate in ALS is proposed (Fig. 7C). In the description of this
model, we will refer to atoms as they are numbered in the
acetolactate product (Fig. 7D), in which C-3 and C-4 are derived
from the first pyruvate, and C-1, C-2, and C-2a are derived
from the second pyruvate. We believe that the covalently bound
intermediate that reacts with the second substrate is a tricyclic
hydroxyethyl carbanion (IVb, Fig. 5), and our proposal (Fig.
7C) is based on modeling this structure. The intermediate
would be planar at C-3 with its methyl group (C-4) interacting
with Met479 and its hydroxyl group pointing toward the solvent
cavity. The re face of the intermediate will be buried in a
hydrophobic cavity (consisting of the side chains of Met394,
Met479, and the -carbon atom of Gln420) and the si face toward
the solvent cavity where the second pyruvate is most likely to
bind.
The formation of V involves the nucleophilic attack of IVb on
the C-2 atom of the second pyruvate. The product released is
acetolactate with a chiral center at C-2. The S-enantiomer is
required for branched-chain amino acid biosynthesis (54), and
we have found by circular dichroism spectroscopy (data not
shown) that the products of ALS and AHAS have the same
stereochemistry. Thus, in order to produce the correct enanti-
omer of acetolactate, the second pyruvate must be bound to
ALS with its C-2 atom close to the C-3 carbanion of the inter-
mediate, and orientated so that it will produce the S-enanti-
omer of acetolactate.
In our model, the second pyruvate is bound in the active site
solvent cavity and with its two carbonyl oxygens displacing two
water molecules that are present in the crystal structures of
ALS containing the intermediate. The C-2 oxygen forms a
hydrogen bond with the backbone nitrogen of Ala35, and the
C-2a methyl group points toward Gln483. The residue corre-
sponding to Gln483 in AHAS is Trp586 (Fig. 7B) and has been
shown to be involved in second substrate specificity (55). Al-
though AHAS favors 2-ketobutyrate as the second substrate,
ALS reacts very poorly with the larger substrate (56). We have
tried to model 2-ketobutyrate into the ALS active site, but this
results in steric clashes between the larger ethyl group of
2-ketobutyrate and the extended side chain of Gln483. In order
to accommodate 2-ketobutyrate, Gln483 would have to adopt an
alternate conformation in which its side chain moves toward
the protein surface and out of the active site. Gln483 may play
a role in ALS catalysis so this drastic change in its conforma-
tion in order to bind to 2-ketobutyrate would prevent reaction
from occurring.
The C-1 carbonyl oxygen of the modeled pyruvate is posi-
tioned in place of a water molecule that is found between and
hydrogen-bonded to the side chains of Gln420 and Gln483. The
nearest carboxylate oxygen of pyruvate is about 4 Å away from
the side chain of Lys36. However, this side chain can be moved
easily so that it could form an ionic interaction with the car-
boxyl group of the second pyruvate, assisting its binding and
orientation. Our model positions the second pyruvate with its
C-2 atom close to the C-3 carbanion (3.8 Å) and in the right
orientation to produce 2S-acetolactate. The second substrate
may be bound in a similar way in AHAS because the architec-
ture of their active sites is very similar (Fig. 7, A and B) and
they produce acetolactate with the same stereochemistry.
Extraneous Ligands
Each monomer in both orthorhombic forms of the enzyme
contains several 7.4 Å long sausage-shaped regions of electron
density in the asymmetric unit, one of which in each monomer
is in a pocket close to the entrance of the channel leading to the
active site. The electron density fits well to diethylene glycol
and may represent an immobile segment of a much larger
molecule, either the precipitant PEG8000 or the cryoprotectant
PEG600. Monomer A of the triclinic form contains two mole-
cules of what appears to be triethylene glycol. In this context
we note that other crystal structures contain ligands modeled
as triethylene glycol, and Lehtio¨ et al. (57) suggest that they are
observing part of a PEG1000 molecule that was used as a
precipitant. Four of the diethylene glycol molecules in each
orthorhombic monomer form two clusters, each of which may
be part of a single PEG molecule. A geometrically plausible
ethyl connection can be made between the two molecules in
each pair, and there is weak electron density in this region
suggestive of such connections.
In all three structures, each monomer contains a tetrahedral
island of electron density in an equivalent position, which was
modeled as a phosphate ion because the enzyme storage buffer
contains 50 mM potassium phosphate. The phosphate ion is
located near the C-terminal end of helix 15/10 at the junction
of the - and -domains. In the crystal structures of yeast
AHAS (9, 40), a potassium ion is found at the equivalent posi-
tion. In AHAS, this cation stabilizes the dipole of its interacting
helix, and it is unexpected for a phosphate ion to be found at the
same location. However, the phosphate ion in ALS is charge-
neutralized by three arginine residues (Arg259, Arg352, and
Arg403) that surround it. Other ligands include the side chain of
Gln266 and a water molecule. This phosphate ion may be func-
tionally significant because it is known that ALS is activated by
acetate, and this activation is reversed by phosphate and sul-
fate (58, 59).
DISCUSSION
FAD and the -Domain—The absence of FAD in ALS and its
presence in AHAS could be explained in two ways. The first
explanation is that ALS comes from the same evolutionary line
as AHAS with both derived from an FAD-dependent pyruvate
oxidase-like ancestor; subsequently, ALS has dispensed with
the requirement for FAD. Alternatively, ALS may have origi-
nated from the same line as the 2-ketoacid decarboxylases that
do not contain FAD, such as pyruvate decarboxylase, indole-
pyruvate decarboxylase, and benzoylformate decarboxylase.
This explanation implies that AHAS and ALS are the result of
convergence of function with respect to the reaction catalyzed.
Phylogenetic analysis of the protein sequences (60) shows that
the ALS sequences cluster closely together and are part of a
larger group that includes pyruvate oxidase and AHAS. The
2-ketoacid decarboxylases form an entirely separate cluster.
These data clearly indicate that ALS comes from the same
pyruvate oxidase-like ancestor as AHAS. FAD has a purely
structural role in AHAS that has been supplanted in ALS by
adjustment of the protein. This has involved a series of amino
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acid substitutions and reorientations that fill the channel oc-
cupied by FAD in AHAS (Fig. 2, C and D).
Structures of the enzymes mentioned above have been pub-
lished (9, 13–18, 40). All have a similar three-domain structure
with a core composed of pairs of - and -domains, with the
-domains on the periphery. The active sites are at the junction
of the -domain of one subunit and the -domain of its neigh-
bor. Also in this structural family is transketolase with the
same three-domain structure but arranged in the sequence ,
, and  (12).
A clear role for the -domain has been established in pyru-
vate oxidase, where it constitutes the major portion of the
binding site for FAD (14), a required participant in catalysis. In
yeast (but not Z. mobilis) pyruvate decarboxylase, an allosteric
activator site that binds pyruvate, is in the -domain (15). We
have suggested (40) that the -domain of yeast AHAS forms
part of the binding site for the regulatory subunit of this en-
zyme. For the other enzymes, the -domain has no obvious
function and appears to serve solely as a scaffolding to support
the - and -domains. Thus, the absence of an FAD-binding site
in the -domain of ALS reflects mutations that have occurred
after separation from the AHAS evolutionary lineage. Given
that pyruvate decarboxylase, benzoylformate decarboxylase,
indolepyruvate decarboxylase, and transketolase can construct
a perfectly satisfactory -domain scaffold without FAD, it is no
great surprise that ALS can do the same.
If the role of the -domain in most of these enzymes is solely
to hold the - and -domains together, then one might easily
imagine related enzymes that have dispensed with the -do-
main entirely by developing appropriate interactions between
the - and -domains. This appears to be the situation in
phosphonopyruvate decarboxylase (61) where the protein se-
quence corresponding to the -domain is missing, whereas in
sulfopyruvate decarboxylase there are separate subunits that
are homologous to the - and -domains, with no equivalent to
the -domain (61). Thus, this entire family of enzymes is con-
structed around the - and -domains. The -domain can be
involved in regulation (yeast pyruvate decarboxylase and per-
haps AHAS), structural integrity (ALS, Z. mobilis pyruvate
decarboxylase, benzoylformate decarboxylase, indolepyruvate
decarboxylase, and transketolase), or not required at all (phos-
phonopyruvate decarboxylase and sulfopyruvate decarboxy-
lase). Only in pyruvate oxidase does the -domain have an
indispensable role in catalysis.
ThDP—There are published structures of representatives of
most major classes of ThDP-dependent enzymes, which show
recognizable common themes in the interactions and conforma-
tion of ThDP. It is anchored to the protein through a divalent
metal ion that ligates to the diphosphate tail and a pair of polar
amino acid side chains from the borders of the thiamine-bind-
ing motif (41). N-1 forms a hydrogen bond to a conserved
glutamate residue that plays an important role in catalysis
(20–24). The cofactor is held in a V conformation by a large
hydrophobic residue that projects between the thiazolium and
methylaminopyrimidine rings. This forces the 4-amino group
into close proximity with C-2 of the thiazolium ring. ThDP in
ALS displays all of these features but differs in one crucial
respect. N-3 of the thiazolium ring is pyramidal in our inter-
pretation, whereas in all of the other structures it is trigonal.
The protein itself does not appear to force this pyramidal con-
formation, so what are the forces that bring about this unique
structure?
An important clue comes from the structure of ALS with the
trapped hydroxyethyl intermediate, where ThDP is in its tri-
cyclic form (29). A similar dihydrothiachrome compound has
been documented previously for thiamine in solution (47, 49,
50), but never before has it been observed in an enzyme. Su-
perimposition of ThDP in the resting enzyme with that in the
intermediate (Fig. 4D) demonstrates that the cofactor atoms
are in very similar positions. Therefore, we suggest that the
resting enzyme contains both the open and tricyclic (IIc, Fig. 5)
forms of ThDP in rapid equilibrium. The proportion of the
dihydrothiachrome form is small enough that it makes no
major contribution to the electron density but large enough to
favor maintenance of N-3 in its pyramidal conformation.
We propose that the tricyclic ThDP reacts with pyruvate
forming the tricyclic lactyl-ThDP (III, Fig. 5). After decarbox-
ylation, the enamine (IVa, Fig. 5) is kinetically stabilized
against reaction with electrophiles because the forced pyrami-
dal N-3 prevents delocalization of electron density from N-3 to
the nucleophilic center at the substrate-derived C-3. The active
site can then pause to release CO2 and admit the second mol-
ecule of pyruvate with no risk of diversion into a non-produc-
tive product. However, during the extended incubation of crys-
tallization, the proximity of N-4 allows occasional reaction at
C-2 of the thiazolium ring and proton transfer to the substrate-
derived C-3 forming IVc (Fig. 5), the product that we have
found.
An intriguing implication of our favored structure for ThDP
and mechanism is that they may explain the unusually high
kcat of K. pneumoniae ALS. The enforced non-planarity at N-3,
which we propose for the reasons described earlier, would re-
sult in a structure in which greater positive charge is distrib-
uted onto C-2, because delocalization of this charge onto N-3
would not be possible and S-1 would be less able to bear
positive charge than N-3, also for the reasons given above. The
result should be a more acidic C-2—H bond. After ionization to
IIa/IIb, cyclization would then produce the nearly localized
carbanion IIc which should exhibit very high nucleophilic re-
activity toward the first pyruvate. By forcing pyramidal geom-
etry at N-3, the enzyme would therefore promote C-2 reactivity
and accelerate the steps leading to lactyl-ThDP (III, Fig. 5),
which are rate-limiting in AHAS (62).
The prevailing evidence (1, 12–19, 26) suggests that the
4-amino group of ThDP, possibly as an imino group in a tau-
tomer of the methylaminopyrimidine ring, functions as a basic
center in C-2 deprotonation. The mechanistic proposal of Fig. 5
can readily accommodate this role. This mechanism is consist-
ent with the structures that we observe and is compatible with
the known chemical properties of ThDP and the catalytic prop-
erties of ThDP-dependent enzymes. We speculate that in ALS
we may be observing forms of the cofactor that are relevant to
other ThDP-dependent enzymes. Perhaps the high kcat of ALS
favors retention of these unusual, but crucial, conformations.
Only the more relaxed structures are observed in other ThDP-
dependent enzymes, because they are less able to keep ThDP in
its most active state.
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